Last reviewed · How we verify
NCT04320199
Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease
NA trial testing Fermented Protaetia brevitarsis seulensis powder group in Alcoholic Liver Disease in 30 participants. Currently enrolling.
30 December 2025
Quick facts
| Lead sponsor | Pusan National University Yangsan Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 January 2020 |
| Primary completion | 30 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Fermented Protaetia brevitarsis seulensis powder group
- Placebo group
Conditions studied
- Alcoholic Liver Disease — all drugs for Alcoholic Liver Disease →
Sponsor
Pusan National University Yangsan Hospital
Who can join
19 and older, any sex, with Alcoholic Liver Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reactive oxygen species (ROS)-mediated oxidative stress in chronic liver diseases and its mitigation by medicinal plants.
Sharma P, Nandave M, Nandave D, Yadav S, et al · · 2023 · cited 20× · PMID 38074830
Verify or expand the search:
- PubMed search for NCT04320199
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcoholic Liver Disease
Currently open trials in the same condition.
- NCT06307964 — Intra-Hepatic Microbiota in Alcoholic Hepatitis · recruiting
- NCT05855031 — The Liver Care Trial · NA · recruiting
- NCT05895890 — French National MICMAF Cohort · recruiting
- NCT05007470 — Alcoholic Liver Disease and the Gut Microbiome · NA · active not recruiting
- NCT04858412 — Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 · NA · recruiting
Other Pusan National University Yangsan Hospital trials
Trials by the same sponsor.
- NCT07511634 — Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Cont · NA · not yet recruiting
- NCT07324226 — Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adul · NA · recruiting
- NCT07334327 — Extracorporeal Blood Purification Using Oxiris for Septic Shock (EXPLORE Study) · NA · not yet recruiting
- NCT07323823 — The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients · NA · not yet recruiting
- NCT07447271 — Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04320199 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pusan National University Yangsan Hospital
- Last refreshed: 4 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04320199.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing